172 related articles for article (PubMed ID: 36551233)
21. Zbed3 promotes proliferation and invasion of lung cancer partly through regulating the function of Axin-Gsk3β complex.
Shi X; Zhao Y; Fan C
J Cell Mol Med; 2019 Feb; 23(2):1014-1021. PubMed ID: 30417576
[TBL] [Abstract][Full Text] [Related]
22. Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration.
Ryu YK; Lee YS; Lee GH; Song KS; Kim YS; Moon EY
Int J Cancer; 2012 Nov; 131(9):2067-77. PubMed ID: 22328534
[TBL] [Abstract][Full Text] [Related]
23. The aurora kinase A regulates GSK-3beta in gastric cancer cells.
Dar AA; Belkhiri A; El-Rifai W
Oncogene; 2009 Feb; 28(6):866-75. PubMed ID: 19060929
[TBL] [Abstract][Full Text] [Related]
24. Glycogen synthase kinase-3β does not correlate with the expression and activity of β-catenin in gastric cancer.
Cho YJ; Yoon J; Ko YS; Kim SY; Cho SJ; Kim WH; Park JW; Youn HD; Kim JH; Lee BL
APMIS; 2010 Oct; 118(10):782-90. PubMed ID: 20854473
[TBL] [Abstract][Full Text] [Related]
25. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
Li HY; Oh YS; Choi JW; Jung JY; Jun HS
Kidney Int; 2017 Jun; 91(6):1362-1373. PubMed ID: 28111010
[TBL] [Abstract][Full Text] [Related]
26. Involvement of LPA signaling via LPA receptor-2 in the promotion of malignant properties in osteosarcoma cells.
Takahashi K; Fukushima K; Tanaka K; Minami K; Ishimoto K; Otagaki S; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2018 Aug; 369(2):316-324. PubMed ID: 29859140
[TBL] [Abstract][Full Text] [Related]
27. A dual role of lysophosphatidic acid type 2 receptor (LPAR2) in nonsteroidal anti-inflammatory drug-induced mouse enteropathy.
Hutka B; Várallyay A; László SB; Tóth AS; Scheich B; Paku S; Vörös I; Pós Z; Varga ZV; Norman DD; Balogh A; Benyó Z; Tigyi G; Gyires K; Zádori ZS
Acta Pharmacol Sin; 2024 Feb; 45(2):339-353. PubMed ID: 37816857
[TBL] [Abstract][Full Text] [Related]
28. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidic acid induces migration of human lung-resident mesenchymal stem cells through the β-catenin pathway.
Badri L; Lama VN
Stem Cells; 2012 Sep; 30(9):2010-9. PubMed ID: 22782863
[TBL] [Abstract][Full Text] [Related]
30. A1CF-Axin2 signal axis regulates apoptosis and migration in Wilms tumor-derived cells through Wnt/β-catenin pathway.
Ni D; Liu J; Hu Y; Liu Y; Gu Y; Zhou Q; Xie Y
In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):252-259. PubMed ID: 30825095
[TBL] [Abstract][Full Text] [Related]
31. TIMMDC1 Knockdown Inhibits Growth and Metastasis of Gastric Cancer Cells through Metabolic Inhibition and AKT/GSK3β/β-Catenin Signaling Pathway.
Liu Y; Huang Y; Zhang J; Pei C; Hu J; Lyu J; Shen Y
Int J Biol Sci; 2018; 14(10):1256-1267. PubMed ID: 30123074
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-338 inhibits proliferation, migration, and invasion of gastric cancer cells by the Wnt/β-catenin signaling pathway.
Song B; Lin HX; Dong LL; Ma JJ; Jiang ZG
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1290-1296. PubMed ID: 29565486
[TBL] [Abstract][Full Text] [Related]
33. Lysophosphatidic acid induces the migration and invasion of SGC-7901 gastric cancer cells through the LPA2 and Notch signaling pathways.
Ren Z; Zhang C; Ma L; Zhang X; Shi S; Tang D; Xu J; Hu Y; Wang B; Zhang F; Zhang X; Zheng H
Int J Mol Med; 2019 Jul; 44(1):67-78. PubMed ID: 31115486
[TBL] [Abstract][Full Text] [Related]
34. Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells.
Shida D; Kitayama J; Yamaguchi H; Hama K; Aoki J; Arai H; Yamashita H; Mori K; Sako A; Konishi T; Watanabe T; Sakai T; Suzuki R; Ohta H; Takuwa Y; Nagawa H
Exp Cell Res; 2004 Dec; 301(2):168-78. PubMed ID: 15530853
[TBL] [Abstract][Full Text] [Related]
35. Lysophosphatidic acid receptor-2 (LPA
Takahashi K; Minami K; Otagaki S; Ishimoto K; Fukushima K; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2018 Sep; 503(4):2698-2703. PubMed ID: 30093116
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
37. LncRNA ZEB2-AS1 contributes to the tumorigenesis of gastric cancer via activating the Wnt/β-catenin pathway.
Wang F; Zhu W; Yang R; Xie W; Wang D
Mol Cell Biochem; 2019 Jun; 456(1-2):73-83. PubMed ID: 30635820
[TBL] [Abstract][Full Text] [Related]
38. 14-3-3σ regulates β-catenin-mediated mouse embryonic stem cell proliferation by sequestering GSK-3β.
Chang TC; Liu CC; Hsing EW; Liang SM; Chi YH; Sung LY; Lin SP; Shen TL; Ko BS; Yen BL; Yet SF; Wu KK; Liou JY
PLoS One; 2012; 7(6):e40193. PubMed ID: 22768254
[TBL] [Abstract][Full Text] [Related]
39. circ_0038718 promotes colon cancer cell malignant progression via the miR-195-5p/Axin2 signaling axis and also effect Wnt/β-catenin signal pathway.
Gu H; Xu Z; Zhang J; Wei Y; Cheng L; Wang J
BMC Genomics; 2021 Oct; 22(1):768. PubMed ID: 34706645
[TBL] [Abstract][Full Text] [Related]
40. A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors.
Su P; Xiao L; Ye L; Wang Z; Xiong W; Wang Q; Ma X; Xian M; Yang M; Zu Y; Pingali SR; Qian J; Yi Q
J Hematol Oncol; 2022 May; 15(1):55. PubMed ID: 35526043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]